id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-D-0375-0004,FDA,FDA-2007-D-0375,Guidance for Industry; Acute Bacterial Sinusitis; Developing Drugs for Treatment,Other,Guidance,2012-10-09T04:00:00Z,2012,10,2012-10-09T04:00:00Z,,2024-11-11T20:42:36Z,,1,0,0900006481138d52
FDA-2007-D-0375-0003,FDA,FDA-2007-D-0375,Guidance for Industry; Availability: Acute Bacterial Sinusitis; Developing Drugs for Treatment,Notice,Notice of Availability,2012-10-09T04:00:00Z,2012,10,2012-10-09T04:00:00Z,,2012-10-09T14:25:37Z,2012-24748,0,0,0900006481138baf
FDA-2007-D-0375-0001,FDA,FDA-2007-D-0375,FDA,Notice,NAD-Notice of Availability of Data,2007-10-30T04:00:00Z,2007,10,2007-10-29T04:00:00Z,2008-01-29T04:59:59Z,2008-07-21T19:57:16Z,,0,0,090000648042c89d
FDA-2007-D-0375-0002,FDA,FDA-2007-D-0375,Guidance,Other,GDL-Guidance (Supporting and Related Materials),2007-10-30T04:00:00Z,2007,10,2007-10-29T04:00:00Z,,2009-01-27T13:28:28Z,,0,0,090000648042c8a1